The Filing Desk

Myomo vs SS Innovations International

Myomo MYO · SS Innovations International SSII · Health Care Equipment

SS Innovations International reported revenue of $42 million in fiscal 2025, about the same as Myomo's $41 million in fiscal 2025. Myomo's revenue grew 25.7% in its latest year, and SS Innovations International's grew 105.7%. Myomo had an operating margin of -35.2%, against -19.3% at SS Innovations International. Free cash flow was −$16 million at Myomo and −$22 million at SS Innovations International.

Side by side

MyomoSS Innovations International
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$41M$42M
Revenue growth25.7%105.7%
Revenue growth a year, last 5 years40.0%—
Gross margin65.7%46.0%
Operating margin−35.2%−19.3%
Net margin−38.0%−28.6%
Free cash flow−$16M−$22M
Free cash flow margin−39.7%−52.3%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count10.8%9.7%
Last close$0.84$1.28
P/E at the last close——
Insider trades, last 12 monthsbought $439,324, sold $102,893bought $5.2 million, sold $99,999
Piotroski F-score3 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
MyomoSS Innovations International
Operating margin
Percent of revenue
MyomoSS Innovations International
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MyomoSS Innovations International

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Myomo and SS Innovations International pages.